IOP, LAURA
 Distribuzione geografica
Continente #
NA - Nord America 5.469
AS - Asia 1.670
EU - Europa 1.451
SA - Sud America 421
AF - Africa 337
OC - Oceania 46
Continente sconosciuto - Info sul continente non disponibili 18
Totale 9.412
Nazione #
US - Stati Uniti d'America 5.290
SG - Singapore 535
CN - Cina 450
IT - Italia 329
BR - Brasile 298
HK - Hong Kong 283
DE - Germania 275
FI - Finlandia 186
SE - Svezia 90
RU - Federazione Russa 69
VN - Vietnam 64
FR - Francia 60
GB - Regno Unito 60
PL - Polonia 49
NL - Olanda 43
UA - Ucraina 32
CI - Costa d'Avorio 29
IN - India 27
AT - Austria 24
IE - Irlanda 23
KR - Corea 22
AR - Argentina 20
ES - Italia 19
MX - Messico 19
CA - Canada 18
TR - Turchia 18
IL - Israele 16
IQ - Iraq 15
UY - Uruguay 15
AU - Australia 13
AZ - Azerbaigian 13
BO - Bolivia 13
BY - Bielorussia 13
LC - Santa Lucia 13
ML - Mali 13
PH - Filippine 13
PY - Paraguay 13
TN - Tunisia 13
VE - Venezuela 13
MU - Mauritius 12
NZ - Nuova Zelanda 12
SA - Arabia Saudita 12
UZ - Uzbekistan 12
AL - Albania 11
BB - Barbados 11
BD - Bangladesh 11
BE - Belgio 11
CH - Svizzera 11
EC - Ecuador 11
EG - Egitto 11
GA - Gabon 11
GP - Guadalupe 11
JM - Giamaica 11
JO - Giordania 11
KZ - Kazakistan 11
LA - Repubblica Popolare Democratica del Laos 11
LU - Lussemburgo 11
NE - Niger 11
PE - Perù 11
PK - Pakistan 11
PS - Palestinian Territory 11
SN - Senegal 11
AM - Armenia 10
BJ - Benin 10
CO - Colombia 10
GH - Ghana 10
ID - Indonesia 10
IR - Iran 10
JP - Giappone 10
RW - Ruanda 10
ZA - Sudafrica 10
ZW - Zimbabwe 10
CL - Cile 9
CM - Camerun 9
CR - Costa Rica 9
DK - Danimarca 9
GM - Gambi 9
HR - Croazia 9
IS - Islanda 9
LV - Lettonia 9
MR - Mauritania 9
PA - Panama 9
AO - Angola 8
CG - Congo 8
CU - Cuba 8
CV - Capo Verde 8
CW - ???statistics.table.value.countryCode.CW??? 8
DZ - Algeria 8
GF - Guiana Francese 8
KE - Kenya 8
LB - Libano 8
MG - Madagascar 8
MY - Malesia 8
NC - Nuova Caledonia 8
NO - Norvegia 8
PT - Portogallo 8
RO - Romania 8
RS - Serbia 8
TJ - Tagikistan 8
TT - Trinidad e Tobago 8
Totale 9.099
Città #
Fairfield 805
Woodbridge 524
Ashburn 480
Chandler 436
Ann Arbor 364
Singapore 340
Houston 318
Seattle 294
Hong Kong 277
Wilmington 273
Cambridge 261
Munich 160
Beijing 147
Boardman 133
Padova 131
Jacksonville 119
Helsinki 104
Santa Clara 98
Princeton 82
San Diego 70
Medford 57
Des Moines 54
Nanjing 48
Roxbury 37
Bytom 36
Los Angeles 32
Abidjan 28
New York 26
São Paulo 25
Hefei 24
Turku 24
Guangzhou 22
Hanoi 20
Dublin 19
Milan 19
Nuremberg 18
Rome 16
Buffalo 14
Rio de Janeiro 14
Seoul 14
Shenyang 14
Castries 13
Dallas 13
Ho Chi Minh City 13
Montevideo 13
Shanghai 13
Vienna 13
Baku 12
Brooklyn 12
Jinan 12
London 12
Redondo Beach 12
Amman 11
Bamako 11
Dakar 11
Hebei 11
Libreville 11
Niamey 11
Vientiane 11
Amsterdam 10
Chicago 10
Kigali 10
San Francisco 10
Tashkent 10
Accra 9
Cotonou 9
Minsk 9
Nouakchott 9
Tunis 9
Antananarivo 8
Asunción 8
Auckland 8
Bridgetown 8
Cagliari 8
Changsha 8
Dushanbe 8
Favaro Veneto 8
Nairobi 8
Nanchang 8
Noumea 8
Praia 8
Riga 8
Yerevan 8
Frankfurt am Main 7
Harare 7
Havana 7
Jiaxing 7
Les Abymes 7
Luanda 7
Lusaka 7
Redwood City 7
Tianjin 7
Tirana 7
Yaoundé 7
Andorra la Vella 6
Chaguanas 6
Falkenstein 6
Jeddah 6
Kingston 6
Lima 6
Totale 6.512
Nome #
A Comprehensive Comparison of Bovine and Porcine Decellularized Pericardia: New Insights for Surgical Applications 306
A Sterilization Method for Decellularized Xenogeneic Cardiovascular Scaffolds 217
Human bone marrow-derived CD133+ cells delivered to a collagen patch on cryoinjured rat heart promote angiogenesis and arteriogenesis. 212
The influence of heart valve leaflet matrix characteristics on the interaction between human mesenchymal stem cells and decellularized scaffolds. 204
Clones of Interstitial Cells From Bovine Aortic Valve Exhibit Different Calcifying Potential When Exposed to Endotoxin and Phosphate 190
Bioengineered tissue solutions for repair, correction and reconstruction in cardiovascular surgery 190
Decellularized aortic conduits: could their cryopreservation affect post-implantation outcomes? A morpho-functional study on porcine homografts 187
Decellularized Allogeneic Heart Valves Demonstrate Self-Regeneration Potential after a Long-Term Preclinical Evaluation 186
Guided Tissue Regeneration in Heart Valve Replacement: From Preclinical Research to First-in-Human Trials 177
Multimodal label-free ex vivo imaging using a dual-wavelength microscope with axial chromatic aberration compensation 177
Different cardiovascular potential of adult- and fetal-type mesenchymal stem cells in a rat model of heart cryoinjury. 173
The Rapidly Evolving Concept of Whole Heart Engineering 167
Nanopatterned acellular valve conduits drive the commitment of blood-derived multipotent cells 165
Preservation strategies for decellularized pericardial scaffolds for off-the-shelf availability 161
Decellularized Cryopreserved Allografts as Off-the-Shelf Allogeneic Alternative for Heart Valve Replacement: In Vitro Assessment Before Clinical Translation 160
Native Bovine and Porcine Pericardia Respond to Load With Additive Recruitment of Collagen Fibers 158
Alpha-Gal detectors in xenotransplantation research: a word of caution. 156
RegenHeart: A Time-Effective, Low-Concentration, Detergent-Based Method Aiming for Conservative Decellularization of the Whole Heart Organ 153
Bioengineered percutaneous heart valves for transcatheter aortic valve replacement: a comparative evaluation of decellularised bovine and porcine pericardia 153
Mechanical testing of pericardium for manufacturing prosthetic heart valves 152
First quantitative assay of alpha-Gal in soft tissues: presence and distribution of the epitope before and after cell removal from xenogeneic heart valves. 152
In vitro comparative assessment of decellularized bovine pericardial patches and commercial bioprosthetic heart valves 152
Neovascularization induced by porous collagen scaffold implanted on intact and cryoinjured rat hearts 148
The Light and Shadow of Senescence and Inflammation in Cardiovascular Pathology and Regenerative Medicine 148
The vietnamese pig as a translational animal model to evaluate tissue engineered heart valves: Promising early experience 144
First quantification of alpha-Gal epitope in current glutaraldehyde-fixed heart valve bioprostheses. 142
Human amniotic fluid-derived stem cells are rejected after transplantation in the myocardium of normal, ischemic, immuno-suppressed or immuno-deficient rat 141
Biocompatibility Evaluation Criteria for Novel Xenograft Materials: Distribution and Quantification of Remnant Nucleic Acid and Alpha-Gal Epitope 141
Interplay of cell-cell contacts and RhoA/MRTF-A signaling regulates cardiomyocyte identity 140
Proteomic analysis of clonal interstitial aortic valve cells acquiring a pro-calcific profile. 139
Dantrolene rescues arrhythmogenic RYR2 defect in a patient-specific stem cell model of catecholaminergic polymorphic ventricular tachycardia. 136
Fibrosis in tissue engineering and regenerative medicine: treat or trigger? 129
Decellularized Porcine Aortic Roots: Histopathology Features in an Experimental Animal Model of Right Ventricular Outflow Tract Reconstruction 127
The role of antibody responses against glycans in bioprosthetic heart valve calcification and deterioration 126
Hybrid membranes for the production of blood contacting surfaces: physicochemical, structural and biomechanical characterization 125
Stem Cell Populations in Human Heart Valves: Identification, Isolation and Characterization in Valve Homografts and Surgical Specimens. 119
Biocompatibility Issues of Next Generation Decellularized Bioprosthetic Devices 119
The Biocompatibility Challenges in the Total Artificial Heart Evolution 119
Xenotransplantation: The Way beyond and Ahead toward Clinical Application 117
Are FDA and CE sacrificing safety for a faster commercialization of xenogeneic tissue devices? Unavoidable need for legislation in decellularized tissue manufacturing 112
Extracellular pyrophosphate is reduced in aortic interstitial valve cells acquiring a calcifying profile: Implications for aortic valve calcification 109
Covalent functionalization of decellularized tissues accelerates endothelialization 106
From the anatomical study to the application of different bioengineering techniques for the creation of new vital heart valve substitutes 102
Mechanical Circulatory Support and Stem Cell-Based Heart Treatment in Europe—2018 Clinical Update 101
NEW ALPHA-GAL REMOVAL ASSAY: PRESENCE AND DISTRIBUTION OF THE EPITOPE BEFORE AND AFTER CELL REMOVAL FROM XENOGENEIC HEART VALVES 100
Proteomic analysis of clonal interstitial aortic valve cells acquiring a pro-calcific profile 100
Spontaneous coronary artery dissection in women with acute myocardial infarction: is there a new role for autoimmunity? 99
Novel heart valve replacement solutions based on self-assembling peptide-functionalized acellular pericardium 96
Bioengineering the Cardiac Conduction System: Advances in Cellular, Gene, and Tissue Engineering for Heart Rhythm Regeneration 96
Association of autoantibodies targeting endothelin type-A receptors with no-reflow in ST-elevation myocardial infarction 95
Inherited and acquired rhythm disturbances in sick sinus syndrome, brugada syndrome, and atrial fibrillation: Lessons from preclinical modeling 95
Spontaneous cell repopulation of valved conduits after decellularization and allogeneic transplantation 92
Time-course evaluation of tissue engineered valved conduits:long term results of porcine decellularized alpha-Gal- valves. 92
Tissue-Guided Regenerated Valved Conduits: Long-Term Results of Porcine Decellularized alpha-Gal Negative Roots 90
AUTOANTIBODIES TARGETING ENDOTHELIN TYPE-A AND ANGIOTENSIN TYPE-1 RECEPTORS ASSOCIATE WITH RISK OF MICROVASCULAR OBSTRUCTION AFTER STEMI 86
FLOGISTIC AND BIOCOMPATIBILITY EFFECTS DETERMINATION OF DECELLULARIZED AND COMMERCIAL AVAILABLE AORTIC LEAFLETS AFTER IMPLANTATION IN A PERITONEAL EXPERIMENTAL RAT MODEL 81
Ischemia sperimentale coronarica nel suino: variazioni anestesiologiche e indotte. 81
Novel heart valve replacement solutions based on self-assembling peptide-functionalized acellular pericardium. 80
Alpha-Gal Removal Tool for the Creation of Xenogenic Biocompatible Heart Valve 80
Antibodies against Angiotensin II Type 1 and Endothelin 1 Type A Receptors in Cardiovascular Pathologies 80
Association of Angiotensin II Receptor Type 1 and Endothelin-1 Receptor Type A Agonistic Autoantibodies With Adverse Remodeling and Cardiovascular Events After Acute Myocardial Infarction 78
Advances in the design, generation, and application of tissue-engineered myocardial equivalents 78
Endotoxin and phosphate may contribute to valve calcification by inducing an osteogenic profile in a specific subset of interstitial aortic valve cells 78
Role of coronary microvascular dysfunction in heart failure with preserved ejection fraction 76
In Vivo Spontaneous Tissue Regeneration Of Allogeneic Decellularized Aortic Valves. 74
Hybrid membranes for blood-contacting surfaces: preliminary characterization 74
Modeling Cardiac Congenital Diseases: From Mathematic Tools to Human Induced Pluripotent Stem Cells 73
Toward the Effective Bioengineering of a Pathological Tissue for Cardiovascular Disease Modeling: Old Strategies and New Frontiers for Prevention, Diagnosis, and Therapy 73
Popolazioni cellulari staminali nelle valvole cardiache umane: identificazione, isolamento e caratterizzazione in homograft valvolari e campioni chirurgici 69
Present and future perspectives on total artificial hearts 69
Cutting-Edge Regenerative Medicine Technologies for the Treatment of Heart Valve Calcification (Chapter 9) 67
Editorial: Insight in heart valve disease: 2021 62
Biocompatibility Evaluation Criteria for Novel Xenograft Materials: Distribution and Quantification of Remnant Nucleic Acid and Alpha-Gal Epitope 62
Abstract 12535: Spontaneous Coronary Artery Dissection in Women: A New Role for Autoimmunity? 61
New Generation Devices for Transcatheter Aortic Valve Implantation 60
Cellular, molecular, genomic changes occurring in the heart under mechanical circulatory support. 59
Evaluation of Decellularized Aortic Valve Leaflets Biocompatibility in a rat model 55
Abstract 12646: Autoantibodies Targeting Endothelin Type-A Receptors Associate With no Reflow After ST-elevation Myocardial Infarction 47
Antibodies against angiotensin II type 1 and endothelin-1 type A receptors are associated with microvascular obstruction after revascularized ST-elevation myocardial infarction 47
Abstract 12559: Functional Autoantibodies Against Angiotensin II Receptor Type 1 and Endothelin-1 Receptor Type A Predict Adverse Remodeling and Cardiovascular Events After Acute Myocardial Infarction 45
Editorial: Vascular and valvular tissue engineering: Treating and modeling vasculopathies and valvulopathies 41
Editorial: Tissue and organ decellularization strategies in regenerative medicine; recent advances, current translational challenges, and future directions 38
Angiotensin II and Atherosclerosis: A New Cardiovascular Risk Factor Beyond Hypertension 26
Totale 9.593
Categoria #
all - tutte 32.712
article - articoli 28.925
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 700
Totale 62.337


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021770 0 0 47 91 42 42 16 71 151 161 92 57
2021/20221.024 28 91 96 181 42 63 46 134 54 9 69 211
2022/2023852 151 107 31 111 117 112 4 64 91 3 50 11
2023/2024416 19 66 47 41 23 29 28 25 20 25 40 53
2024/20252.077 10 115 77 94 244 99 169 187 206 72 326 478
2025/20261.923 417 639 867 0 0 0 0 0 0 0 0 0
Totale 9.593